Sep 27, 2012
Agfa HealthCare launches SKINTELL high-definition OCT
MORTSEL, BELGIUM, 26 September 2012 – Agfa HealthCare announces today that it will launch its SKINTELL high-definition optical coherence tomography (HD-OCT) solution at the 21st congress of the European Academy of Dermatology and Venereology (EADV) in Prague. This non-invasive imaging technology allows the examination of the epidermal morphology and superficial dermis, potentially avoiding a biopsy.
Speed and comfort for patient and doctor
SKINTELL HD-OCT non-invasively visualizes skin layers up to 1mm in depth, with no discomfort for the patient. It offers three viewing modes: slice, 3D and the unique en face, which gives a parallel perspective to the skin, in real time.
The 3 µm high-resolution solution, which can be adapted to all skin types, provides views in all three dimensions of the epidermal layers and the dermal-epidermal junction down to the upper part of collagen tissue. A 3D image takes one second.
Complements and adds to dermatological examinations
"SKINTELL is a truly new solution for dermatologists, dermato-oncologists, plastic surgeons and the cosmetic industry, and it is backed by several Agfa HealthCare patents," comments Dirk Debusscher, Vice President Imaging at Agfa HealthCare. "It complements current dermatological examinations, combining the advantages of several types of exams, but with a speed and comfort that will be appreciated by doctor and patient alike. For example, it provides a subcutaneous view not possible with dermatoscopy, a deeper view than confocal microscopy, and 3D zoom for regions of interest."
Fits in daily practice and with advanced technologies
Dr. Marc Boone uses SKINTELL HD-OCT at his dermatology practice near Brussels, Belgium. "My patients appreciate the speed and real-time analysis of the image. It creates confidence in the doctor," he comments. Dr. Boone uses all advanced imaging technologies, such as digital microscopy, high-frequency ultrasound and confocal scanning microscopy.
Dr. Tanja Maier uses SKINTELL HD-OCT at the Ludwig-Maximilians-Universität in Munich, Germany. She comments: "SKINTELL offers the possibility of immediate imaging of epithelial skin cancer and has potential in the non-invasive monitoring of skin tumors under topical treatment. It facilitates and accelerates the process of evaluation in daily practice."
Prof. Dr. Johannes Wohlrab performed a successful pre-clinical trial at the Martin-Luther-Universität Halle-Wittenberg, Halle, Germany. He states: "We have validated the HD-OCT solution SKINTELL in comparison with high frequency ultrasound (50 MHz) and presented the potential of a non-invasive depiction of the epidermal structures in particular. In my opinion, the clinical use of SKINTELL can enhance the non-invasive diagnostics of intra-epidermal processes considerably."